NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

Popular weight loss drug, semaglutide, could be shrinking the muscle tissue in the heart, a new study has found. In recent ...

But as semaglutide weight loss medications like Ozempic, Wegovy and others become household names, people trying to lose weight are exploring adding medications to their weight loss toolkit.

Unsurprisingly, the patients taking the active semaglutide lost way more weight than their placebo counterparts — but they also experienced dramatic reductions in their pain scales, with an ...

A study released this week has found that a majority of American adults are eligible to take semaglutide, the active ingredient in the medications Wegovy and Ozempic. Scientists at Harvard and ...

Tirzepatide treatment led to a 47% greater relative reduction in weight compared with semaglutide. Topline results were announced from a phase 3b clinical trial comparing tirzepatide with ...

One very successful drug for type 2 diabetes management is semaglutide. It works as a glucagon-like peptide 1 (GLP-1) agonist, stimulating insulin release and reducing glucagon secretion ...

Odds are you eligible for a prescription for semaglutide, the popular diabetes and weight loss drug better known by the brand names Ozempic and Wegovy. More than half of U.S. adults – 136.8 mill ...

Semaglutide, the diabetes drug also known as Ozempic, has shown positive effects in treating patients with chronic kidney disease (CKD) and obesity, as revealed in an international study led by ...

Novo Nordisk-sponsored studies lasting up to two years show that semaglutide is safe. Another study from Novo Nordisk on higher doses of semaglutide than those used for Ozempic spanned four years.